Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1970 1
1971 1
1980 2
1984 1
1986 1
1987 2
1988 1
1989 1
1990 1
1991 1
1994 2
1999 1
2002 2
2003 1
2004 2
2005 2
2006 1
2007 5
2008 8
2009 2
2010 5
2011 4
2012 5
2013 5
2014 6
2015 6
2016 6
2017 8
2018 6
2019 5
2020 4
2021 8
2022 12
2023 10
2024 9
2025 14
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean D. ivkovic (26 results)?
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.
Welsh JA, Goberdhan DCI, O'Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrügger U, Falcon-Perez JM, Fu QL, Hill AF, Lenassi M, Lim SK, Mahoney MG, Mohanty S, Möller A, Nieuwland R, Ochiya T, Sahoo S, Torrecilhas AC, Zheng L, Zijlstra A, Abuelreich S, Bagabas R, Bergese P, Bridges EM, Brucale M, Burger D, Carney RP, Cocucci E, Crescitelli R, Hanser E, Harris AL, Haughey NJ, Hendrix A, Ivanov AR, Jovanovic-Talisman T, Kruh-Garcia NA, Ku'ulei-Lyn Faustino V, Kyburz D, Lässer C, Lennon KM, Lötvall J, Maddox AL, Martens-Uzunova ES, Mizenko RR, Newman LA, Ridolfi A, Rohde E, Rojalin T, Rowland A, Saftics A, Sandau US, Saugstad JA, Shekari F, Swift S, Ter-Ovanesyan D, Tosar JP, Useckaite Z, Valle F, Varga Z, van der Pol E, van Herwijnen MJC, Wauben MHM, Wehman AM, Williams S, Zendrini A, Zimmerman AJ; MISEV Consortium; Théry C, Witwer KW. Welsh JA, et al. J Extracell Vesicles. 2024 Feb;13(2):e12404. doi: 10.1002/jev2.12404. J Extracell Vesicles. 2024. PMID: 38326288 Free PMC article.
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome.
Al-Hakem H, Doets AY, Stino AM, Zivkovic SA, Andersen H, Willison HJ, Cornblath DR, Gorson KC, Islam Z, Mohammad QD, Sindrup SH, Kusunoki S, Davidson A, Casasnovas C, Bateman K, Miller JAL, van den Berg B, Verboon C, Roodbol J, Leonhard SE, Arends S, Luijten LWG, Benedetti L, Kuwabara S, Van den Bergh P, Monges S, Marfia GA, Shahrizaila N, Galassi G, Pereon Y, Bürmann J, Kuitwaard K, Kleyweg RP, Marchesoni C, Sedano Tous MJ, Querol L, Martín-Aguilar L, Wang Y, Nobile-Orazio E, Rinaldi S, Schenone A, Pardo J, Vermeij FH, Waheed W, Lehmann HC, Granit V, Stein B, Cavaletti G, Gutiérrez-Gutiérrez G, Barroso FA, Visser LH, Katzberg HD, Dardiotis E, Attarian S, van der Kooi AJ, Eftimov F, Wirtz PW, Samijn JPA, Gilhuis HJ, Hadden RDM, Holt JKL, Sheikh KA, Kolb N, Karafiath S, Vytopil M, Antonini G, Feasby TE, Faber C, Kramers H, Busby M, Roberts RC, Silvestri NJ, Fazio R, van Dijk GW, Garssen MPJ, Verschuuren J, Harbo T, Jacobs BC; IGOS Consortium. Al-Hakem H, et al. Neurology. 2023 Jun 6;100(23):e2386-e2397. doi: 10.1212/WNL.0000000000207282. Epub 2023 Apr 19. Neurology. 2023. PMID: 37076309 Free PMC article.
BOPPY-based novel fluorescent dopamine D(2) and D(3) receptor ligands.
Elek M, Dubiel M, Mayer L, Zivkovic A, Müller TJJ, Stark H. Elek M, et al. Bioorg Med Chem Lett. 2022 Mar 1;59:128573. doi: 10.1016/j.bmcl.2022.128573. Epub 2022 Jan 19. Bioorg Med Chem Lett. 2022. PMID: 35063632
Its out-of-range concentration can lead to various neurological diseases with special interest for dopamine D(2) and D(3) receptor subtypes. Although BODIPY is a highly versatile structural moiety for fluorescence labeling, we have looked out for structurally relate …
Its out-of-range concentration can lead to various neurological diseases with special interest for dopamine D(2) and D(3) rece …
Aromatic linker variations in novel dopamine D(2) and D(3) receptor ligands.
Di Biase C, Leitzbach L, Frank A, Zivkovic A, Stark H. Di Biase C, et al. Arch Pharm (Weinheim). 2024 Aug;357(8):e2400071. doi: 10.1002/ardp.202400071. Epub 2024 May 12. Arch Pharm (Weinheim). 2024. PMID: 38736025
Dopamine D(2)-like receptors, especially D(2) and D(3) receptor subtypes, are important targets of antipsychotic agents. ...N-(4-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}phenyl)acetamide (6c) demonstrates the highest D(3)R and D(2)R affinity …
Dopamine D(2)-like receptors, especially D(2) and D(3) receptor subtypes, are important targets of antipsychotic agents …
Specific inhibition of fibroblast growth factor receptor 1 signaling by a DNA aptamer.
Zlinska V, Feketova Z, Czyrek A, Chudzian J, Zivkovic ML, Ursachi VC, Dudeja P, Fafilek B, Rynes J, Rico-Llanos G, Koudelka A, Roy T, Biadun M, Raskova V, Svozilova K, Stroblova M, Krzyscik M, Hristova K, Krowarsch D, Foldynova-Trantirkova S, Zakrzewska M, Trantirek L, Krejci P. Zlinska V, et al. Mol Ther Nucleic Acids. 2024 Nov 28;36(1):102405. doi: 10.1016/j.omtn.2024.102405. eCollection 2025 Mar 11. Mol Ther Nucleic Acids. 2024. PMID: 39759879 Free PMC article.
In the search for specific inhibitors of human FGFR1, we identified VZ23, a DNA aptamer that binds to FGFR1b and FGFR1c with a K(D) of 55 nM and 162 nM, respectively, but not to the other FGFR variants (FGFR2b, FGFR2c, FGFR3b, FGFR3c, FGFR4). ...
In the search for specific inhibitors of human FGFR1, we identified VZ23, a DNA aptamer that binds to FGFR1b and FGFR1c with a K(D) o …
von Willebrand disease-specific defects and proteomic signatures in endothelial colony-forming cells.
Laan SNJ, Groten S, Dirven RJ, Bürgisser PE, Leebeek FWG, van Moort I, van den Biggelaar M, Bierings R, Eikenboom J; SYMPHONY consortium. Laan SNJ, et al. J Thromb Haemost. 2025 Aug;23(8):2634-2650. doi: 10.1016/j.jtha.2025.04.024. Epub 2025 May 6. J Thromb Haemost. 2025. PMID: 40339962 Free article.
OBJECTIVES: We analyzed the endothelial compartment of VWD patients with an unexplained decrease in VWF level or nonresponse to 1-8-deamino-D-arginine vasopressin (DDAVP) using endothelial colony-forming cells (ECFCs). METHODS: Thirteen healthy controls and 10 VWD type 1 a …
OBJECTIVES: We analyzed the endothelial compartment of VWD patients with an unexplained decrease in VWF level or nonresponse to 1-8-deamino- …
A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials.
Potter S, Avery K, Ahmed R, de Boniface J, Chatterjee S, Dodwell D, Dubsky P, Federmann J, Finestone S, Gnant M, Hlauschek D, Iwata H, Jiang MY, Kaidar-Person O, Lee HB, MacKenzie M, Meyn A, Poortmans P, Poulakaki F, Richardson AL, Sepulveda KA, Spillane AJ, Thompson AM, Werutsky G, Wittmann P, Wright JL, Zdenkowski N, Cowan K, McIntosh SA; PRECEDENT Study Group. Potter S, et al. NPJ Breast Cancer. 2025 Oct 28;11(1):116. doi: 10.1038/s41523-025-00824-w. NPJ Breast Cancer. 2025. PMID: 41152314 Free PMC article.
The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.
Zivković M, Starčević Čizmarević N, Lovrečić L, Klupka-Sarić I, Stanković A, Gašparović I, Lavtar P, Dinčić E, Stojković L, Rudolf G, Jazbec SS, Perković O, Sinanović O, Sepčić J, Kapović M, Peterlin B, Ristić S. Zivković M, et al. Dis Markers. 2014;2014:362708. doi: 10.1155/2014/362708. Epub 2014 Apr 16. Dis Markers. 2014. PMID: 24825926 Free PMC article.
In the present study, an association of the TPA Alu I/D and PAI-1 4G/5G polymorphisms with MS was analyzed within the Genomic Network for Multiple Sclerosis (GENoMS). ...
In the present study, an association of the TPA Alu I/D and PAI-1 4G/5G polymorphisms with MS was analyzed within the Genomic Network …
146 results